Your browser doesn't support javascript.
loading
The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-oncogene MYC and Molecular Programs Central to Barrett's Neoplasia.
Venkitachalam, Srividya; Babu, Deepak; Ravillah, Durgadevi; Katabathula, Ramachandra M; Joseph, Peronne; Singh, Salendra; Udhayakumar, Bhavatharini; Miao, Yanling; Martinez-Uribe, Omar; Hogue, Joyce A; Kresak, Adam M; Dawson, Dawn; LaFramboise, Thomas; Willis, Joseph E; Chak, Amitabh; Garman, Katherine S; Blum, Andrew E; Varadan, Vinay; Guda, Kishore.
Afiliação
  • Venkitachalam S; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Babu D; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Ravillah D; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Katabathula RM; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Joseph P; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Singh S; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Udhayakumar B; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Miao Y; Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Martinez-Uribe O; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina.
  • Hogue JA; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina.
  • Kresak AM; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Dawson D; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • LaFramboise T; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Willis JE; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Chak A; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Garman KS; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina.
  • Blum AE; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, Ohio; Division of Gastroenterology, Northeast Ohio
  • Varadan V; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: varadan@gmail.com.
  • Guda K; Division of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Pathology, Case Western Reserv
Gastroenterology ; 163(5): 1228-1241, 2022 11.
Article em En | MEDLINE | ID: mdl-35870513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Carcinoma de Células Escamosas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Carcinoma de Células Escamosas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article